Zydus Lifesciences Limited has informed the Exchange regarding a press release dated January 12, 2023, titled "Zydus receivesfinal approval and 180 days shared exclusivity from the USFDA for Brexpiprazole Tablets".
Zydus Lifesciences Limited Press Release Jan 12 2023
Filed with NSE ·
6ix hasn’t read this filing yet.
Zydus Lifesciences Limited on 6ix
Earlier from Zydus Lifesciences
- Press Release Jan 10 2023
- Press Release Jan 06 2023
- Press Release Dec 30 2022
- Loss of Share Certificates
- Press Release Dec 22 2022
Later from Zydus Lifesciences
- Zydus Lifesciences Limited Press Release Jan 16 2023
- Press Release Jan 27 2023
- Press Release Feb 15 2023
- Zydus Lifesciences Limited Press Release Feb 17 2023
- Zydus Lifesciences Limited Press Release Feb 20 2023
Follow Zydus Lifesciences into a list and get an email when it puts out news.
Follow Zydus Lifesciences